Edge Therapeutics (NASDAQ: EDGE ): FY GAAP EPS of -$1.31. More news on: Edge Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
BERKELEY HEIGHTS, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the full-year ended December 31, 2018. Financial Results Cash Position: Cash and cash equivalents totaled $34.6 million at December 31, 2018, compa...
Edge Therapeutics (NASDAQ: EDGE ): Q3 GAAP EPS of -$0.14. More news on: Edge Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
BERKELEY HEIGHTS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the quarter ended September 30, 2018. Third Quarter Financial Results Cash Position: Cash, cash equivalents and marketable securities as of Septemb...
News, Short Squeeze, Breakout and More Instantly...
Edge Therapeutics Inc. Company Name:
EDGE Stock Symbol:
NASDAQ Market:
BERKELEY HEIGHTS, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the full-year ended December 31, 2018. Financial Results Cash Position: Cash and cash equivalents totaled $34.6 million at December 31, 2018, compa...
BERKELEY HEIGHTS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE) today announced financial results for the quarter ended September 30, 2018. Third Quarter Financial Results Cash Position: Cash, cash equivalents and marketable securities as of Septemb...